- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有19家主力机构披露2026-06-30报告期持股数据，持仓量总计3.85亿股，占流通A股32.56%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了47%的股票
技术面评分前10的股票
近期的平均成本为0.00元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为0.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"0.00","date":1793693565,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.11.04","stock":"2.67","trade":"2.96","ind":"4.22"},{"date":"2026.11.03","stock":"0.00","trade":"-0.88","ind":"-1.21"},{"date":"2026.11.02","stock":"3.15","trade":"1.70","ind":"1.63"},{"date":"2026.10.30","stock":"-1.55","trade":"-1.05","ind":"-2.73"},{"date":"2026.10.29","stock":"-3.73","trade":"-1.88","ind":"-2.92"},{"date":"2026.10.28","stock":"1.13","trade":"1.46","ind":"2.02"},{"date":"2026.10.27","stock":"-2.93","trade":"-3.85","ind":"-2.50"},{"date":"2026.10.26","stock":"-0.73","trade":"0.14","ind":"-1.19"},{"date":"2026.10.23","stock":"0.73","trade":"1.64","ind":"2.79"},{"date":"2026.10.22","stock":"-4.55","trade":"-3.34","ind":"-2.96"},{"date":"2026.10.21","stock":"0.35","trade":"0.13","ind":"-0.82"},{"date":"2026.10.20","stock":"0.71","trade":"1.00","ind":"-0.14"},{"date":"2026.10.19","stock":"-4.07","trade":"-1.42","ind":"0.13"},{"date":"2026.10.16","stock":"-1.67","trade":"-0.03","ind":"-0.12"},{"date":"2026.10.15","stock":"0.00","trade":"-1.39","ind":"-2.43"},{"date":"2026.10.14","stock":"-4.15","trade":"-1.41","ind":"-1.97"},{"date":"2026.10.13","stock":"1.29","trade":"-0.78","ind":"-0.25"},{"date":"2026.10.12","stock":"-6.65","trade":"-2.33","ind":"-2.03"},{"date":"2026.10.09","stock":"5.08","trade":"1.57","ind":"0.17"},{"date":"2026.10.08","stock":"-0.63","trade":"-1.77","ind":"-2.07"},{"date":"2026.09.30","stock":"-1.25","trade":"2.11","ind":"-0.11"}]
华仁药业,深证成指,化学制药指数
压力支撑
该股压力位为2.63元，支撑位为2.58元。
[{"text":"\u538b\u529b\u4f4d","value":"2.63","date":1793721600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"2.58","date":1793721600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了12%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月04日 20:30
| 机构今日流向(万元) | 2451.72 | 机构5日流向(万元) | 1930.80 |
| 机构10日流向(万元) | -1110.11 | 机构20日流向(万元) | -10100.75 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少2499.84万股，其中基金净减仓5家，主力净减仓45家，请投资者中长期谨慎为宜。
截止2026-06-30，共19家主力机构（基金15家，一般法人4家），持仓量总计38472.12万股，占流通A股32.56%
其中，基金持仓与2025-12-31相比：
增仓：2家 ，增持 13.73万股
减仓：7家 ，减持 18.55万股
新出现在主力名单中：6家 ，持有43.8万股
从主力名单中消失：51家 ，原持有916.78万股
其中，基金持仓与2025-12-31相比：
增仓：2家 ，增持 13.73万股
减仓：7家 ，减持 18.55万股
新出现在主力名单中：6家 ，持有43.8万股
从主力名单中消失：51家 ，原持有916.78万股
消息面诊股
诊断结果：5.3消息面打败了28%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 高盛现身20只低价A股：从我爱我家到思创智联，有增
2026-11-04 - 华仁药业：11月3日获融资买入1189.81万元
2026-11-04 - 华仁药业：10月30日获融资买入1095.10万元
2026-11-02 - 华仁药业：关于公司董事、高级管理人员增持公司股份计
2026-10-30 - 华仁药业：陈志国等拟增持公司股份，不低于人民币10
2026-10-30 - 喜报！华仁药业日照公司复合磷酸氢钾注射液获批上市
2026-10-30 - 华仁药业：10月29日获融资买入892.45万元
2026-10-30 - 华仁药业：10月28日获融资买入1156.34万元
2026-10-29 - 华仁药业：10月27日获融资买入972.16万元
2026-10-28 - 股东追踪|张青等新进华仁药业前十大流通股东
2026-10-28
消息列表
| 一般消息 | 高管变动 | 因任期届满 | 2026-09-14 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-27 |
| 一般消息 | 高管变动 | 为进一步完善公司治理架构，适应公司... | 2026-08-25 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-07-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 高管变动 | 根据公司经营管理需要 | 2026-05-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-24 |
| 一般消息 | 高管变动 | 不再聘任 | 2026-04-22 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-30 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.2行业面打败了90%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.11.04","price":"4.22","value":"2.96"},{"date":"2026.11.03","price":"-1.21","value":"-0.88"},{"date":"2026.11.02","price":"1.63","value":"1.70"},{"date":"2026.10.30","price":"-2.73","value":"-1.05"},{"date":"2026.10.29","price":"-2.92","value":"-1.88"},{"date":"2026.10.28","price":"2.02","value":"1.46"},{"date":"2026.10.27","price":"-2.50","value":"-3.85"},{"date":"2026.10.26","price":"-1.19","value":"0.14"},{"date":"2026.10.23","price":"2.79","value":"1.64"},{"date":"2026.10.22","price":"-2.96","value":"-3.34"},{"date":"2026.10.21","price":"-0.82","value":"0.13"},{"date":"2026.10.20","price":"-0.14","value":"1.00"},{"date":"2026.10.19","price":"0.13","value":"-1.42"},{"date":"2026.10.16","price":"-0.12","value":"-0.03"},{"date":"2026.10.15","price":"-2.43","value":"-1.39"},{"date":"2026.10.14","price":"-1.97","value":"-1.41"},{"date":"2026.10.13","price":"-0.25","value":"-0.78"},{"date":"2026.10.12","price":"-2.03","value":"-2.33"},{"date":"2026.10.09","price":"0.17","value":"1.57"},{"date":"2026.10.08","price":"-2.07","value":"-1.77"},{"date":"2026.09.30","price":"-0.11","value":"2.11"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 莱美药业 | 71.40% | -3.93% | 5.7分 |
| 2 | 海欣股份 | 14.12% | 3.90% | 5.5分 |
| 3 | 海正药业 | 13.96% | -0.07% | 5.7分 |
| 4 | 昂利康 | 10.63% | 9.11% | 5.5分 |
| 5 | 迪哲医药 | 10.50% | 10.33% | 6.1分 |
| 6 | 健康元 | 9.21% | 3.82% | 6.7分 |
| 8 | 华邦健康 | 7.60% | 11.19% | 6.3分 |
| 10 | 科伦药业 | 6.78% | 9.25% | 5.6分 |
| 12 | - | 4.19% | 6.79% | 分 |
| 14 | 恒瑞医药 | 3.92% | 1.43% | 6.7分 |
| 16 | 京新药业 | 2.87% | 9.94% | 6.4分 |
| 18 | 海辰药业 | 2.66% | -4.36% | 5.6分 |
| 20 | 东诚药业 | 1.55% | 1.71% | 5.4分 |
| 22 | 亿帆医药 | 1.17% | 3.14% | 6.0分 |
| 24 | 恩华药业 | 0.18% | 6.75% | 6.2分 |
| 26 | 百济神州 | -0.19% | 3.73% | 4.3分 |
| 28 | - | -0.52% | 2.18% | 分 |
| 30 | 华润双鹤 | -0.68% | 3.86% | 5.6分 |
| 32 | 兴齐眼药 | -1.07% | 9.68% | 6.1分 |
| 34 | 通化金马 | -2.04% | 0.34% | 5.7分 |
| 36 | 北大医药 | -2.39% | -1.30% | 4.7分 |
| 38 | 诚意药业 | -2.58% | 4.93% | 5.8分 |
| 40 | 共同药业 | -3.70% | 0.00% | 4.9分 |
| 42 | 海普瑞 | -4.26% | 2.39% | 5.9分 |
| 44 | 贝达药业 | -4.38% | 18.11% | 6.5分 |
| 46 | 华北制药 | -4.62% | 1.06% | 4.5分 |
| 48 | 天新药业 | -4.66% | -0.64% | 4.4分 |
| 50 | 翰宇药业 | -5.06% | -1.94% | 4.8分 |
| 52 | 海思科 | -5.11% | 2.16% | 6.9分 |
| 54 | 吉贝尔 | -5.85% | -2.33% | 4.2分 |
| 56 | - | -6.21% | -4.07% | 分 |
| 58 | 海翔药业 | -6.50% | -1.03% | 5.4分 |
| 60 | 力生制药 | -6.75% | 3.55% | 4.6分 |
| 62 | 德展健康 | -7.12% | 3.45% | 4.9分 |
| 64 | 司太立 | -7.31% | 1.37% | 4.9分 |
| 66 | 天宇股份 | -7.76% | 1.41% | 6.0分 |
| 68 | 奥锐特 | -8.12% | 0.55% | 4.5分 |
| 70 | 石药景峰 | -8.18% | 6.38% | 5.5分 |
| 72 | ST复华 | -8.68% | -3.00% | 4.3分 |
| 74 | 卫信康 | -8.91% | -2.01% | 4.4分 |
| 76 | - | -9.11% | -7.15% | 分 |
| 78 | 尔康制药 | -9.51% | 4.24% | 5.1分 |
| 80 | ST能特 | -10.00% | -4.88% | 4.9分 |
| 82 | 浙江医药 | -10.14% | 2.48% | 5.3分 |
| 84 | - | -10.38% | -3.35% | 分 |
| 86 | 康芝药业 | -10.80% | 0.21% | 4.9分 |
| 88 | 一品红 | -11.27% | 1.37% | 5.7分 |
| 90 | - | -11.69% | -8.11% | 分 |
| 92 | 民生健康 | -12.00% | 2.79% | 5.5分 |
| 94 | 海南海药 | -12.55% | 0.25% | 4.6分 |
| 96 | - | -12.97% | -2.42% | 分 |
| 98 | 奥翔药业 | -13.08% | -2.05% | 3.8分 |
| 100 | 亚太药业 | -13.57% | -0.67% | 4.5分 |
| 102 | 本立科技 | -13.76% | -3.89% | 5.0分 |
| 104 | 国邦医药 | -13.99% | 5.06% | 5.3分 |
| 106 | 新天地 | -14.23% | -3.65% | 5.0分 |
| 108 | 广济药业 | -14.76% | -4.92% | 4.8分 |
| 110 | 华仁药业 | -15.14% | 0.37% | 4.9分 |
| 112 | 罗欣药业 | -15.35% | 0.49% | 5.2分 |
| 114 | 盟科药业 | -15.57% | -0.20% | 4.4分 |
| 116 | 西点药业 | -15.85% | -4.08% | 5.1分 |
| 118 | 凯因科技 | -16.02% | -2.76% | 4.6分 |
| 120 | 北陆药业 | -16.32% | -0.87% | 5.3分 |
| 122 | 汇宇制药 | -16.50% | -2.19% | 4.3分 |
| 124 | 润都股份 | -16.59% | 1.43% | 5.3分 |
| 126 | 泽璟制药 | -17.15% | 1.28% | 4.7分 |
| 128 | 微芯生物 | -17.53% | 1.22% | 4.8分 |
| 130 | 冀衡医药 | -17.79% | -2.01% | 4.3分 |
| 132 | 誉衡药业 | -18.08% | 1.36% | 5.3分 |
| 134 | 中哲精化 | -19.23% | -3.59% | 5.0分 |
| 136 | 花园生物 | -19.53% | 1.47% | 4.8分 |
| 138 | 圣诺生物 | -19.61% | 0.81% | 5.1分 |
| 140 | 悦康药业 | -20.09% | -7.81% | 3.6分 |
| 142 | 宣泰医药 | -21.13% | -5.36% | 4.2分 |
| 144 | 神奇制药 | -21.37% | 1.42% | 5.1分 |
| 146 | 哈三联 | -22.36% | 0.50% | 5.2分 |
| 148 | 宏辉果蔬 | -22.65% | -7.72% | 4.3分 |
| 150 | *ST集友 | -22.99% | -3.71% | 4.3分 |
| 152 | 亚虹医药 | -23.29% | -0.44% | 4.3分 |
| 154 | 必贝特 | -25.86% | 7.56% | 5.0分 |
| 156 | 石药创新 | -26.76% | -9.62% | 5.0分 |
| 158 | 益方生物 | -27.37% | 1.91% | 4.2分 |
| 160 | 多瑞医药 | -28.29% | -11.26% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 89/218 ， 110/218。
[{"date":"2026-09-30","value":"3.16","vol":"-3.64"},{"date":"2026-06-30","value":"3.35","vol":"-0.06"},{"date":"2026-03-31","value":"1.89","vol":"0.46"},{"date":"2025-12-31","value":"-43.29","vol":"-1.74"},{"date":"2025-09-30","value":"4.11","vol":"1.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.16 | 3.35 | 1.89 | -43.29 | 4.11 |
| 行业(%) | -3.64 | -0.06 | 0.46 | -1.74 | 1.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"31.61","vol":"49.28"},{"date":"2026-06-30","value":"32.63","vol":"49.07"},{"date":"2026-03-31","value":"33.25","vol":"50.10"},{"date":"2025-12-31","value":"37.05","vol":"49.45"},{"date":"2025-09-30","value":"34.15","vol":"49.28"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
31.61 | 32.63 | 33.25 | 37.05 | 34.15 |
| 行业(%) | 49.28 | 49.07 | 50.10 | 49.45 | 49.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 109/218 ， 124/218。
[{"date":"2026-09-30","value":"-10.48","vol":"42.64"},{"date":"2026-06-30","value":"-3.02","vol":"19.66"},{"date":"2026-03-31","value":"2.14","vol":"23.45"},{"date":"2025-12-31","value":"-2.34","vol":"37.42"},{"date":"2025-09-30","value":"-9.07","vol":"139.36"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-10.48 | -3.02 | 2.14 | -2.34 | -9.07 |
| 行业(%) | 42.64 | 19.66 | 23.45 | 37.42 | 139.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"-50.69","vol":"149.72"},{"date":"2026-06-30","value":"-23.55","vol":"353.66"},{"date":"2026-03-31","value":"-0.44","vol":"48.30"},{"date":"2025-12-31","value":"66.17","vol":"-23.63"},{"date":"2025-09-30","value":"-42.87","vol":"3.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-50.69 | -23.55 | -0.44 | 66.17 | -42.87 |
| 行业(%) | 149.72 | 353.66 | 48.30 | -23.63 | 3.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 63/218 ， 34/218。
[{"date":"2026-09-30","value":"0.32","vol":"0.31"},{"date":"2026-06-30","value":"0.22","vol":"0.21"},{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.43","vol":"0.41"},{"date":"2025-09-30","value":"0.29","vol":"0.30"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.32 | 0.22 | 0.11 | 0.43 | 0.29 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.41 | 0.30 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.51","vol":"1.94"},{"date":"2026-06-30","value":"1.69","vol":"1.30"},{"date":"2026-03-31","value":"0.85","vol":"0.65"},{"date":"2025-12-31","value":"2.97","vol":"2.59"},{"date":"2025-09-30","value":"2.25","vol":"1.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.51 | 1.69 | 0.85 | 2.97 | 2.25 |
| 行业(次) | 1.94 | 1.30 | 0.65 | 2.59 | 1.94 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"19.80","vol":"-0.33"},{"date":"2026-06-30","value":"20.61","vol":"5.40"},{"date":"2026-03-31","value":"4.60","vol":"-2.46"},{"date":"2025-12-31","value":"38.71","vol":"15.68"},{"date":"2025-09-30","value":"24.63","vol":"4.82"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 19.80 | 20.61 | 4.60 | 38.71 | 24.63 |
| 行业 | -0.33 | 5.40 | -2.46 | 15.68 | 4.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.17","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.42","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.17 | - | 0.42 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.59 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 87/218 ， 46/218。
[{"date":"2026-09-30","value":"0.85","vol":"3.64"},{"date":"2026-06-30","value":"0.80","vol":"3.68"},{"date":"2026-03-31","value":"0.82","vol":"3.65"},{"date":"2025-12-31","value":"0.67","vol":"3.44"},{"date":"2025-09-30","value":"0.74","vol":"3.52"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.85 | 0.80 | 0.82 | 0.67 | 0.74 |
| 行业 | 3.64 | 3.68 | 3.65 | 3.44 | 3.52 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.62","vol":"2.95"},{"date":"2026-06-30","value":"0.58","vol":"2.98"},{"date":"2026-03-31","value":"0.59","vol":"3.01"},{"date":"2025-12-31","value":"0.48","vol":"2.82"},{"date":"2025-09-30","value":"0.55","vol":"2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.62 | 0.58 | 0.59 | 0.48 | 0.55 |
| 行业 | 2.95 | 2.98 | 3.01 | 2.82 | 2.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 53/218 ， 10/218。
[{"date":"2026-09-30","value":"65.48","vol":"32.58"},{"date":"2026-06-30","value":"65.83","vol":"33.24"},{"date":"2026-03-31","value":"66.79","vol":"32.97"},{"date":"2025-12-31","value":"66.36","vol":"34.15"},{"date":"2025-09-30","value":"58.02","vol":"33.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
65.48 | 65.83 | 66.79 | 66.36 | 58.02 |
| 行业(%) | 32.58 | 33.24 | 32.97 | 34.15 | 33.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.05","vol":"0.66"},{"date":"2026-06-30","value":"2.09","vol":"0.70"},{"date":"2026-03-31","value":"2.18","vol":"9.64"},{"date":"2025-12-31","value":"2.14","vol":"1.73"},{"date":"2025-09-30","value":"1.45","vol":"1.17"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.05 | 2.09 | 2.18 | 2.14 | 1.45 |
| 行业(%) | 0.66 | 0.70 | 9.64 | 1.73 | 1.17 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.81","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.88","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-13.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-4.63","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]